Keros Therapeutics, Inc. Shares Outstanding (Cover Page)
Keros Therapeutics, Inc. (KROS) had Shares Outstanding (Cover Page) of 19.83 million shares as of 2026-07-27, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-03
- 2026-07-27: Entity Common Stock, Shares Outstanding 19.83M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 19.79M shares.
- 2026-02-27: Entity Common Stock, Shares Outstanding 19.72M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 30.47M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-27 | 19.83M shares 10-Q · filed 2026-08-03 |
| 2026-05-08 | 19.79M shares 10-Q · filed 2026-05-14 |
| 2026-02-27 | 19.72M shares 10-K · filed 2026-03-04 |
| 2025-10-31 | 30.47M shares 10-Q · filed 2025-11-05 |
| 2025-07-31 | 40.62M shares 10-Q · filed 2025-08-06 |
| 2025-05-01 | 40.62M shares 10-Q · filed 2025-05-06 |
| 2025-02-20 | 40.56M shares 10-K · filed 2025-02-26 |
| 2024-10-31 | 40.51M shares 10-Q · filed 2024-11-06 |
| 2024-07-31 | 37.52M shares 10-Q · filed 2024-08-07 |
| 2024-05-01 | 36.08M shares 10-Q · filed 2024-05-08 |
| 2024-02-21 | 35.98M shares 10-K · filed 2024-02-28 |
| 2023-10-31 | 29.96M shares 10-Q · filed 2023-11-06 |
| 2023-07-28 | 29.66M shares 10-Q · filed 2023-08-07 |
| 2023-04-27 | 29.58M shares 10-Q · filed 2023-05-04 |
| 2023-02-23 | 28.54M shares 10-K · filed 2023-03-03 |
| 2022-10-27 | 27.54M shares 10-Q · filed 2022-11-03 |
| 2022-07-29 | 25.76M shares 10-Q · filed 2022-08-04 |
| 2022-04-29 | 24.03M shares 10-Q · filed 2022-05-05 |
| 2022-03-02 | 24.00M shares 10-K · filed 2022-03-09 |
| 2021-10-28 | 23.40M shares 10-Q · filed 2021-11-04 |
| 2021-07-27 | 23.34M shares 10-Q · filed 2021-08-05 |
| 2021-04-29 | 23.30M shares 10-Q · filed 2021-05-06 |
| 2021-03-19 | 23.27M shares 10-K · filed 2021-03-25 |
| 2020-11-03 | 20.19M shares 10-Q · filed 2020-11-10 |
| 2020-08-07 | 20.17M shares 10-Q · filed 2020-08-13 |
| 2020-05-15 | 20.15M shares 10-Q · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |